Results 51 to 60 of about 945,906 (220)
Updates on transcatheter aortic valve replacement: Techniques, complications, outcome, and prognosis
Journal of the Saudi Heart Association, 2018 Transcatheter aortic valve replacement (TAVR) initially emerged as a therapeutic option for high-risk patients with severe aortic stenosis. Advancement in technologies since the first era of TAVRs, experience from previous obstacles, and lessons learned ...
Jarrah Alfadhli +3 more
doaj +1 more source
Advanced Science, EarlyView.In human CAVD, KLF5 is reduced in VIC‐rich regions and remodeling/stress‐associated VIC states. In VICs, KLF5 sustains BNIP3 promoter activity and BNIP3‐mediated mitophagy, thereby limiting cytosolic mtDNA accumulation. KLF5 loss weakens mitochondrial quality control and enhances mtDNA‐sensitive STING/NF‐κB/NLRP3 inflammatory signaling under osteogenic
Jin‐Hui Bian +13 more
wiley +1 more source
Comparative evaluation of left ventricular mass regression after aortic valve replacement: a prospective randomized analysis [PDF]
, 2011 Background: We assessed the hemodynamic performance of various prostheses and the clinical outcomes after aortic valve replacement, in different age groups.
Wood Jeffrey P +11 more
core +2 more sources
, 2023 Trends in treatment of AS (SAVR, TAVR) SAVR: Surgical aortic valve replacement, TAVR: Transcatheter aortic valve replacement.
Yunus Ahmed (10777076) +9 more
core +1 more source
Brazilian Journal of Cardiovascular Surgery, 2016 Objective: Transcatheter aortic valve implantation has recently been used in the treatment of severe aortic valve stenosis, particularly in patients with high mortality and morbidity rates for open surgery.
Cemal Kocaaslan +7 more
doaj +1 more source
Advanced Intelligent Systems, EarlyView.A unifying device–cardiovascular interface framework is presented to classify implantable cardiovascular technologies as intracardiovascular blood‐contacting systems or extracardiovascular tissue‐only and blood‐handling architectures. Cross‐class comparison across shared semiquantitative criteria, including blood‐contact burden, biomimicry ...
Bergo Nicolò +7 more
wiley +1 more source
Transcatheter Aortic Valve Replacement and Stroke [PDF]
Circulation: Cardiovascular Interventions, 2015 The evaluation of any therapy includes an assessment of benefits and risks. For percutaneous coronary interventions, death and myocardial infarction are typically selected as the 2 hard end points for describing adverse events. Stroke may be observed during percutaneous coronary intervention and be a direct result of the procedure.
Neil J, Wimmer, David O, Williams
openaire +2 more sources
BMEMat, EarlyView.The challenges of bioprosthetic heart valves (BHV) with respect to calcification, infection, and poor durability are tackled by surface engineering of hyperbranched poly‐L‐lysine (HBPL), providing a translational solution to improve long‐term valve performance.
Pai Peng +7 more
wiley +1 more source
Gutter Rotation Technique for Percutaneous Ipsilateral Retrieval of a Ruptured SAPIEN‐3 Balloon
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Balloon rupture during transcatheter aortic valve replacement (TAVR) with balloon‐expandable valves is a rare but potentially serious complication that may result in incomplete valve expansion, difficult device retrieval, and vascular injury.
Anne Venkata Ganeshkumar +5 more
wiley +1 more source
Predicting mortality after transcatheter aortic valve replacement external validation of the Transcatheter Valve Therapy registry model [PDF]
, 2017 BACKGROUND: The Transcatheter Valve Therapy (TVT) registry model was recently developed to predict the risk of in-hospital mortality in patients undergoing transcatheter aortic valve replacement.
Oliver Muller +69 more
core +4 more sources